|
Regulation
Citations 201-210 of 217 total displayed.
|
Past content
(since Jul 1999):
|
- Commentary
Substance use: time for drug law reform
- Catherine Hankins
Can. Med. Assoc. J. 2000; 162: 1693-1694.
[Full text]
[PDF]
- Letters
Access to the morning-after pill in BC
- William D. Gutowski
Can. Med. Assoc. J. 2000; 162: 1554-a-1555-a.
[Full text]
[PDF]
- Letters
Access to the morning-after pill in BC
- Brenda Osmond
Can. Med. Assoc. J. 2000; 162: 1554.
[Full text]
[PDF]
- Editorial
Tobacco in the courts
-
Can. Med. Assoc. J. 2000; 162: 1265.
[Full text]
[PDF]
[ [Français] ]
- News
Despite some opposition, BC pharmacists to dispense morning-after pill without prescription
- Barbara Sibbald
Can. Med. Assoc. J. 2000; 162: 876-877.
[Full text]
[PDF]
- Research
Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998
- Nigel S.B. Rawson
Can. Med. Assoc. J. 2000; 162: 501-504.
[Abstract]
[Full text]
[PDF]
[ Appendix 1 ]
- Review
Pharmaceutical policies in Canada: another example of federal-provincial discord
- Aslam H. Anis
Can. Med. Assoc. J. 2000; 162: 523-526.
[Abstract]
[Full text]
[PDF]
- News
Loophole closure outrages generic drug companies
- David Helwig
Can. Med. Assoc. J. 2000; 162: 396.
[Full text]
[PDF]
- Commentary
The need for greater involvement of regulatory agencies in assessing adverse drug reactions
- Allan D. Sniderman
Can. Med. Assoc. J. 2000; 162: 209-210.
[Full text]
[PDF]
- Commentary
Scientific harassment by pharmaceutical companies: time to stop
- David Hailey
Can. Med. Assoc. J. 2000; 162: 212-213.
[Full text]
[PDF]
|
|
